Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis
- PMID: 29596982
- PMCID: PMC6160359
- DOI: 10.1016/j.cgh.2018.03.024
Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis
Conflict of interest statement
Comment in
-
The Potential Role of Vedolizumab in Concomitant Eosinophilic Esophagitis and Crohn's Disease.Clin Gastroenterol Hepatol. 2018 Nov;16(11):1840-1841. doi: 10.1016/j.cgh.2018.06.022. Clin Gastroenterol Hepatol. 2018. PMID: 30343868 No abstract available.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
